You are here:

insulin degludec (Tresiba)

Advice

in the absence of a submission from the holder of the marketing authorisation

insulin degludec (Tresiba) is not recommended for use within NHS Scotland.

Indication under review: Treatment of diabetes mellitus in adolescents and children from the age of 1 year.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

SMC previously assessed insulin degludec (Tresiba) for the treatment of diabetes mellitus in adults (856/13) and advised that it is not recommended for use within NHS Scotland.

Drug Details

Drug Name: insulin degludec (Tresiba)
SMC Drug ID: 1060/15
Manufacturer: Novo Nordisk Ltd
Indication: Treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.
BNF Category:
Sub Category: 6.1 Drugs used in diabetes
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 11 May 2015

Back